{"pmid":32439732,"title":"Are stethoscopes risky in COVID-19?","text":["Are stethoscopes risky in COVID-19?","Postgrad Med J","Lau, Yuk-Fai","Wei, William","Lau, Chu-Pak","32439732"],"journal":"Postgrad Med J","authors":["Lau, Yuk-Fai","Wei, William","Lau, Chu-Pak"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439732","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/postgradmedj-2020-138085","keywords":["audiology","cardiology","infection control"],"topics":["Prevention"],"weight":1,"_version_":1667535119545532416,"score":9.490897,"similar":[{"pmid":32366178,"title":"Defining Essential Services for Deaf and Hard of Hearing Children during the COVID-19 Pandemic.","text":["Defining Essential Services for Deaf and Hard of Hearing Children during the COVID-19 Pandemic.","COVID-19 is a rapidly growing global pandemic caused by a novel coronavirus. With no vaccine or definitive treatment, public health authorities have recommended a strategy of \"social distancing,\" reducing individual interaction, canceling elective procedures, and limiting nonessential services. Health care providers must determine what procedures are considered \"elective,\" balancing risk of treatment delays with that of coronavirus exposure to patient, family, and providers. Given critical periods for language development and the long-term impact of auditory deprivation, some audiologic and otologic services should be considered essential. In this article, we describe the experience of a quaternary referral pediatric hospital in Seattle, the epicenter of COVID-19 in the United States, and share strategies for risk minimization employed by Seattle Children's Hospital. We hope that this work can be a reference for other centers continuing care for children who are deaf and hard of hearing during the COVID-19 and future resource-limiting crises.","Otolaryngol Head Neck Surg","Pattisapu, Prasanth","Evans, Sean S","Noble, Anisha R","Norton, Susan J","Ou, Henry C","Sie, Kathleen C Y","Horn, David L","32366178"],"abstract":["COVID-19 is a rapidly growing global pandemic caused by a novel coronavirus. With no vaccine or definitive treatment, public health authorities have recommended a strategy of \"social distancing,\" reducing individual interaction, canceling elective procedures, and limiting nonessential services. Health care providers must determine what procedures are considered \"elective,\" balancing risk of treatment delays with that of coronavirus exposure to patient, family, and providers. Given critical periods for language development and the long-term impact of auditory deprivation, some audiologic and otologic services should be considered essential. In this article, we describe the experience of a quaternary referral pediatric hospital in Seattle, the epicenter of COVID-19 in the United States, and share strategies for risk minimization employed by Seattle Children's Hospital. We hope that this work can be a reference for other centers continuing care for children who are deaf and hard of hearing during the COVID-19 and future resource-limiting crises."],"journal":"Otolaryngol Head Neck Surg","authors":["Pattisapu, Prasanth","Evans, Sean S","Noble, Anisha R","Norton, Susan J","Ou, Henry C","Sie, Kathleen C Y","Horn, David L"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366178","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1177/0194599820925058","keywords":["covid-19","audiology","hearing loss","pandemic","pediatric otolaryngology"],"locations":["Seattle","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138496225509376,"score":61.881435},{"pmid":32396446,"title":"Otologic and Audiologic Considerations for COVID-19.","text":["Otologic and Audiologic Considerations for COVID-19.","The COVID-19 pandemic has created a number of considerations for otolaryngology; anosmia and ageusia in particular have gained significant attention. Here we present considerations in regard to treatment with quinine-derived drugs and the influence of masks on communication.","Otolaryngol Head Neck Surg","Eby, Thomas L","Arteaga, Alberto A","Spankovich, Christopher","32396446"],"abstract":["The COVID-19 pandemic has created a number of considerations for otolaryngology; anosmia and ageusia in particular have gained significant attention. Here we present considerations in regard to treatment with quinine-derived drugs and the influence of masks on communication."],"journal":"Otolaryngol Head Neck Surg","authors":["Eby, Thomas L","Arteaga, Alberto A","Spankovich, Christopher"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396446","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/0194599820928989","keywords":["covid-19","audiology","chloroquine","communication","hydroxychloroquine","otology"],"topics":["Prevention"],"weight":1,"_version_":1666627827974275073,"score":61.881435},{"pmid":32363352,"pmcid":"PMC7194973","title":"COVID-19: A United Kingdom National Health Service cardiology perspective.","text":["COVID-19: A United Kingdom National Health Service cardiology perspective.","JACC Case Rep","Collins, George B","Jenner, William J","Kaier, Thomas E","Bhattacharyya, Sanjeev","32363352"],"journal":"JACC Case Rep","authors":["Collins, George B","Jenner, William J","Kaier, Thomas E","Bhattacharyya, Sanjeev"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363352","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaccas.2020.04.024","keywords":["covid-19","cardiology","national health service","sars-cov-2","united kingdom","coronavirus"],"topics":["Prevention"],"weight":1,"_version_":1666138496026279936,"score":56.109142},{"pmid":32405088,"pmcid":"PMC7219407","title":"Cardiological society of India position statement on COVID-19 and heart failure.","text":["Cardiological society of India position statement on COVID-19 and heart failure.","The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority.","Indian Heart J","Harikrishnan, S","Mohanan, P P","Chopra, V K","Ambuj, Roy","Sanjay, G","Manish, Bansal","Chakraborty, R N","Chandra, Sharad","Chattarjee, S S","Chopra, H K","Mathew, Cibu","Deb, P K","Goyal, A","Goswami, K C","Gupta, R","Guha, S","Gupta, V","Hasija, P K","Wardhan, Harsh","Jabir, A","Jayagopal, P B","Kahali, D","Katyal, V K","Kerkar, P G","Khanna, N N","Majumder, B","Mandal, M","Meena, C B","Naik, N","Narain, V K","Pathak, L A","Ray, S","Roy, D","Sarma, D","Shanmugasundaram, S","Singh, B P","Tyagi, S K","Venugopal, K","Wander, G S","Yadav, R","Das, M K","32405088"],"abstract":["The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority."],"journal":"Indian Heart J","authors":["Harikrishnan, S","Mohanan, P P","Chopra, V K","Ambuj, Roy","Sanjay, G","Manish, Bansal","Chakraborty, R N","Chandra, Sharad","Chattarjee, S S","Chopra, H K","Mathew, Cibu","Deb, P K","Goyal, A","Goswami, K C","Gupta, R","Guha, S","Gupta, V","Hasija, P K","Wardhan, Harsh","Jabir, A","Jayagopal, P B","Kahali, D","Katyal, V K","Kerkar, P G","Khanna, N N","Majumder, B","Mandal, M","Meena, C B","Naik, N","Narain, V K","Pathak, L A","Ray, S","Roy, D","Sarma, D","Shanmugasundaram, S","Singh, B P","Tyagi, S K","Venugopal, K","Wander, G S","Yadav, R","Das, M K"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405088","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ihj.2020.04.012","keywords":["covid-19","csi","heart failure","cardiology","corona"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666802845342498817,"score":56.109142},{"pmid":32473301,"title":"Surveillance for COVID-19 in cardiac inpatients: containing COVID-19 in a specialised cardiac centre.","text":["Surveillance for COVID-19 in cardiac inpatients: containing COVID-19 in a specialised cardiac centre.","Can J Cardiol","Wee, Liang En","Wen, Ruan","Jean Sim, Xiang Ying","Ng, Kym","Phoon, Poh Choo","Conceicao, Edwin Philip","Aung, May Kyawt","Lung Wong, Aaron Sung","Chua, Terrance Siang Jin","Venkatachalam, Indumathi","32473301"],"journal":"Can J Cardiol","authors":["Wee, Liang En","Wen, Ruan","Jean Sim, Xiang Ying","Ng, Kym","Phoon, Poh Choo","Conceicao, Edwin Philip","Aung, May Kyawt","Lung Wong, Aaron Sung","Chua, Terrance Siang Jin","Venkatachalam, Indumathi"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473301","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.cjca.2020.05.031","keywords":["covid-19","cardiology","fluid overload","viral respiratory infection"],"topics":["Prevention"],"weight":1,"_version_":1668255193263767553,"score":56.109142}]}